PAUL DEUTSCH: Open Payments
NPI 1811990013 · NORWICH, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,321 in 151 payments from 41 companies in 2025. Trend: 2023 $3,037 · 2024 $3,931 · 2025 $3,321
Food & beverage: $3,321
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $264 |
| GlaxoSmithKline, LLC. | 14 | $261 |
| PFIZER INC. | 14 | $260 |
| AstraZeneca Pharmaceuticals LP | 11 | $247 |
| Phathom Pharmaceuticals, Inc. | 10 | $212 |
| Novo Nordisk Inc | 10 | $200 |
| Antares Pharma, Inc. | 1 | $166 |
| Astellas Pharma US Inc | 8 | $157 |
| Exact Sciences Corporation | 5 | $133 |
| Lilly USA, LLC | 5 | $125 |
Products named: TRELEGY ELLIPTA, VOQUEZNA, XYOSTED, Veozah, EVENITY, JARDIANCE, The Cologuard Plus Collection Kit, ELIQUIS.
Industry payments across CT — which companies pay providers there.
